2001
DOI: 10.2337/diabetes.50.3.593
|View full text |Cite
|
Sign up to set email alerts
|

GLUT4 Overexpression in db/db Mice Dose-Dependently Ameliorates Diabetes But Is Not a Lifelong Cure

Abstract: We previously reported that overexpression of GLUT4 in lean, nondiabetic C57BL/KsJ-lepr db/؉ (db/؉) mice resulted in improved glucose tolerance associated with increased basal and insulin-stimulated glucose transport in isolated skeletal muscle. We used the diabetic (db/db) litter mates of these mice to examine the effects of GLUT4 overexpression on in vivo glucose utilization and on in vitro glucose transport and GLUT4 translocation in diabetic mice. We examined in vivo glucose disposal by oral glucose challe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
41
0
2

Year Published

2001
2001
2020
2020

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(45 citation statements)
references
References 32 publications
(46 reference statements)
2
41
0
2
Order By: Relevance
“…Diabetic db/db mice exhibit profound insulin resistance in vivo (9). Therefore, the objective of this investigation was to assess cardiac insulin sensitivity by using isolated cardiomyocytes from control and db/db mice.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Diabetic db/db mice exhibit profound insulin resistance in vivo (9). Therefore, the objective of this investigation was to assess cardiac insulin sensitivity by using isolated cardiomyocytes from control and db/db mice.…”
Section: Discussionmentioning
confidence: 99%
“…At 8 -12 wk, diabetic db/db mice exhibit glucose intolerance in response to an oral glucose challenge (18) and a reduced hypoglycemic response to a bolus injection of insulin (21) compared with nondiabetic control db/ϩ mice. Severe insulin resistance is also observed with hyperglycemic hyperinsulinemic clamps (9). Recently, Carley et al (10) reported that chronic (6 wk) oral administration of an insulin-sensitizing peroxisome proliferator-activated receptor-␥ (PPAR␥) agonist (COOH) to db/db mice improved diabetic status by normalizing hyperglycemia.…”
mentioning
confidence: 98%
“…This raises the question of whether AMPK activation can improve defects in insulin action and metabolism arising from severe obesity from either leptin deficiency or impaired leptin signaling. For example, in severely obese diabetic leptin receptor-deficient db/db mice, GLUT4 overexpression can improve glucose tolerance (25) as well as skeletal muscle insulin sensitivity (26). Furthermore, AMPK activation by AICAR treatment improves glucose homeostasis in rodents (5,7).…”
Section: R225qmentioning
confidence: 99%
“…Overexpression of GLUT4 protein may alleviate insulin resistance (29,30). The animals with overexpression of GLUT4 protein may have improved glucose uptake and utilization, and this may significantly increase insulin sensitivity.…”
Section: Discussionmentioning
confidence: 99%